September 28, 2021 – The U.S. Preventive Services Task Force released today a final recommendation statement on aspirin use to prevent preeclampsia and related morbidity and mortality. The Task Force recommends low-dose aspirin for pregnant people at increased risk for preeclampsia. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. The final recommendation statement can also be found in the September 28, 2021 online issue of JAMA.
